Johnson & Johnson Innovation Opens JLABS @ Toronto

TORONTO, May 11, 2016 Johnson & Johnson Innovation announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they work to build important and successful early-stage companies. The new JLABS facility can accommodate up to 50 startups and opens with 22 companies that represent a range of sectors including therapeutics, medical devices and consumer health solutions.

OBIO would like to congratulate its members who were selected as part of the first 22 companies in the new space.

For the full press release, click here.

Previous
Previous

SCIENION inks Joint Development and Marketing pact with AXELA

Next
Next

OBIO Hosts Annual Celebration of the Health Sciences Industry in Canada